Researchers analyzed 177,919 residual test specimens from commercial laboratories nationwide. Samples were obtained during four separate collection periods between July 27 and Sept. 24.
Researchers’ estimates of antibody prevalence ranged from less than 1 percent to 23 percent depending on the city or jurisdiction. In most areas, less than 10 percent of the population had detectable antibodies as of September.
Overall, the Northeast had the highest antibody levels, though estimates varied widely by jurisdiction. New York also had the highest percentage of people with antibodies at 23.3 percent during the first specimen collection period.
To view the full study, click here.
More articles on public health:
COVID-19 death rates by state: Nov. 25
22 states where COVID-19 is spreading fastest, slowest: Nov. 25
CDC may shorten 14-day COVID-19 quarantine recommendation
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
